Chlorine Triggers Protective Nerve Receptor

Apr 09, 2008
Chlorine Triggers Protective Nerve Receptor
Airway nerve cells exposed to chlorine. Bright color indicates excitation of some nerve cells.

Inhaling chlorine triggers a nerve receptor that protects healthy people by inducing sneezing, coughing, and irritation, but can cause major problems for people with asthma and other respiratory problems, Yale School of Medicine researchers report today in the Journal of Clinical Investigation.

Prior to this study it was thought that chlorine and other oxidants induced pain and inflammation only through tissue injury. But the Yale team observed that mice lacking the receptor TRPA1 were insensitive to exposure to chlorine—which is used in industrial synthesis, for disinfection of drinking water and swimming pools, and in household bleach. Interestingly, the receptor is the same one triggered by pungent mustard and noxious chemicals in cigarette smoke.

“We show that chlorine activates a specific receptor, TRPA1, in pain-sensing nerve endings in the airways,” said corresponding author, Sven-Eric Jordt, assistant professor of pharmacology. “We identified a population of neurons that fire in response to chlorine exposure, inducing pain and irritation, and narrowing airway passages—probably to protect the lung from chlorine damage.”

The problem with this response, he said, is that people whose respiratory systems already are compromised by asthma or congestion from colds and allergies then have a hypersensitive response to chemicals—their lungs are already doing what the brain is telling the respiratory system to do to protect itself.

“In these patients chlorine and other TRPA1 activators can trigger constriction of the bronchial pathways, and cause pain and discomfort in the airways,” Jordt said.

The silver lining, said Jordt, is that the study points to TRPA1 as a promising new target for the development of new drugs to suppress coughs and relieve pain and inflammation.

The lead authors are Bret Bessac and Michael Sivula of Yale. The study was conducted in collaboration with the laboratory of Lauren Cohn in the pulmonary section of Internal Medicine at Yale and funded by grants from the National Institute of Environmental Health Sciences of the National Institutes of Health.

Source: Yale University

Explore further: Research milestone in CCHF virus could help identify new treatments

add to favorites email to friend print save as pdf

Related Stories

Germany's Bayer says will float chemicals division

28 minutes ago

German chemicals and pharmaceuticals giant Bayer, maker of Aspirin painkiller, said on Thursday it intends to float its chemicals Material Science division to focus on its life sciences activities in human and animal health.

Scientists monitoring Hawaii lava undertake risks

38 minutes ago

New photos from the U.S. Geological Survey's Hawaiian Volcano Observatory give a glimpse into the hazardous work scientists undertake to monitor lava that's threatening to cross a major highway.

Recommended for you

A new way to prevent the spread of devastating diseases

15 hours ago

For decades, researchers have tried to develop broadly effective vaccines to prevent the spread of illnesses such as HIV, malaria, and tuberculosis. While limited progress has been made along these lines, ...

New molecule allows for increase in stem cell transplants

16 hours ago

Investigators from the Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal have just published, in the prestigious magazine Science, the announcement of the discovery of a new molecule, the fi ...

Team explores STXBP5 gene and its role in blood clotting

18 hours ago

Two independent groups of researchers led by Sidney (Wally) Whiteheart, PhD, of the University of Kentucky, and Charles Lowenstein, MD, of the University of Rochester, have published important studies exploring the role that ...

User comments : 0